In the past week, ARTL stock has gone down by -10.53%, with a monthly gain of 2.59% and a quarterly surge of 1.71%. The volatility ratio for the week is 8.13%, and the volatility levels for the last 30 days are 6.25% for Artelo Biosciences Inc The simple moving average for the last 20 days is -4.68% for ARTL’s stock, with a simple moving average of -3.48% for the last 200 days.
Is It Worth Investing in Artelo Biosciences Inc (NASDAQ: ARTL) Right Now?
The stock has a 36-month beta value of 1.05. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ARTL is 3.20M, and at present, short sellers hold a 0.27% of that float. On February 17, 2025, the average trading volume of ARTL was 35.93K shares.
ARTL) stock’s latest price update
Artelo Biosciences Inc (NASDAQ: ARTL)’s stock price has dropped by -14.39 in relation to previous closing price of 1.39. Nevertheless, the company has seen a loss of -10.53% in its stock price over the last five trading days. globenewswire.com reported 2025-02-14 that SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological conditions, today announced nonclinical results on ART12.11, its proprietary cocrystal composition of cannabidiol (CBD) and tetramethylpyrazine (TMP).
Analysts’ Opinion of ARTL
Many brokerage firms have already submitted their reports for ARTL stocks, with Ladenburg Thalmann repeating the rating for ARTL by listing it as a “Buy.” The predicted price for ARTL in the upcoming period, according to Ladenburg Thalmann is $7 based on the research report published on February 12, 2021 of the previous year 2021.
ARTL Trading at 3.32% from the 50-Day Moving Average
After a stumble in the market that brought ARTL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.00% of loss for the given period.
Volatility was left at 6.25%, however, over the last 30 days, the volatility rate increased by 8.13%, as shares surge +4.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.21% upper at present.
During the last 5 trading sessions, ARTL fell by -10.53%, which changed the moving average for the period of 200-days by -10.53% in comparison to the 20-day moving average, which settled at $1.2485. In addition, Artelo Biosciences Inc saw 12.26% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ARTL
The total capital return value is set at -0.53. Equity return is now at value -87.12, with -80.59 for asset returns.
Based on Artelo Biosciences Inc (ARTL), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -127.11. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -2057.4.
Currently, EBITDA for the company is -10.29 million with net debt to EBITDA at 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.15.
Conclusion
To sum up, Artelo Biosciences Inc (ARTL) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
